These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4573913)

  • 1. [Effect of beta-methyl-digoxin on the hemodynamics of patients with heart failure].
    Lang E; Pollmer R; Schoedel J; Köhler JA; Durst OE
    Fortschr Med; 1973 Apr; 91(12):543-4 passim. PubMed ID: 4573913
    [No Abstract]   [Full Text] [Related]  

  • 2. Digoxin in the management of cardiovascular disorders.
    Gheorghiade M; Adams KF; Colucci WS
    Circulation; 2004 Jun; 109(24):2959-64. PubMed ID: 15210613
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of the pharmacokinetic, pharmacodynamic and clinical studies of digoxin use].
    Kukes VG; Volkov RIu; Ibadova D; Shokhor VIa
    Ter Arkh; 1985; 57(12):59-62. PubMed ID: 4089770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of digoxin, furosemide and finoptin on the central hemodynamics in hypertension].
    Orynchak Ma
    Vrach Delo; 1989 Mar; (3):35-8. PubMed ID: 2750115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Digoxin in chronic heart failure and sinus rhythm: is the end of the controversy in sight?].
    van Veldhuisen DJ; de Graeff PA; Crijns HJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(10):460-4. PubMed ID: 9173285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of the therapeutic effect of beta-methyldigoxin].
    Sorrentino F; Andreozzi GM; Carrubba A; Cottini E; Mossuti E
    Minerva Cardioangiol; 1973 Mar; 21(3):222-30. PubMed ID: 4575391
    [No Abstract]   [Full Text] [Related]  

  • 7. [Digoxin reduces morbidity, but not mortality in patients with heart failure].
    Brunner-La Rocca HP
    Praxis (Bern 1994); 1997 Oct; 86(40):1563-4. PubMed ID: 9417573
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrasting effect on cardiac output of digoxin and gitoxin in humans during congestive heart failure.
    Col J; Wijns W; Brasseur L; Lesne M
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):314-8. PubMed ID: 7263109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complex assessment of treatment effectiveness in cardiopulmonary failure using digoxin controlled by determining its concentration in the blood plasma].
    Sidorova LD; Arkhipova GF; Kudelia LM; Pavlova II; Petrenko VK
    Ter Arkh; 1987; 59(10):47-51. PubMed ID: 3433219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on digoxin therapy in congestive heart failure.
    Haji SA; Movahed A
    Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nitrates in the combined treatment of congestive heart failure patients in a mountainous location].
    Mirrakhimov MM; Moldotashev IK; Kadyraliev KK
    Klin Med (Mosk); 1986 Apr; 64(4):62-5. PubMed ID: 2941617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiac therapy using -methyl digoxin].
    Rummel W; Niederländer K
    Munch Med Wochenschr; 1972 May; 114(19):930-2. PubMed ID: 4559200
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gradulon in the treatment of heart insufficiency with simultaneous cardiocirculatory load].
    Grossmann D; Mishra BR
    Med Welt; 1974 May; 25(22):1006-9. PubMed ID: 4605687
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of ramipril in treating patients with chronic heart failure].
    Sinitsina II; Orlov VA; Zakharova GIu; Giliarevskiĭ SR; Ivasenko LA
    Ter Arkh; 1995; 67(5):75-7. PubMed ID: 7638788
    [No Abstract]   [Full Text] [Related]  

  • 15. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA
    Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The left ventricular systolic function after digoxin administration in patients with chronic renal failure.
    Trznadel K; Luciak M; Wyszogrodzka M
    Clin Nephrol; 1980 May; 13(5):231-4. PubMed ID: 7398145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of digoxin in heart failure. Should we bother?
    Frank J; Evans MF
    Can Fam Physician; 1997 Jul; 43():1227-8. PubMed ID: 9241459
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled clinical trial of beta-methyl digoxin].
    Vrhovac B; Gjurasin M; Bakran I; Bubanj D; Custović F; Duraković Z
    Lijec Vjesn; 1975 May; 97(5):299-306. PubMed ID: 1107731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of the effect of digoxin, strophanthin, isolanid and corglycon on the indices of central hemodynamics, vascular tonus, circulating blood volume and myocardial contractility in acute heart failure].
    Tsyganiĭ AA; Kovalev NL; Kozlovskiĭ VI; Malinovskiĭ OP; Pen'kov GI
    Anesteziol Reanimatol; 1981; (3):44-8. PubMed ID: 7294441
    [No Abstract]   [Full Text] [Related]  

  • 20. Heart rate variability in infants with heart failure due to congenital heart disease: reversal of depressed heart rate variability by propranolol.
    Buchhorn R; Hulpke-Wette M; Nothroff J; Paul T
    Med Sci Monit; 2002 Oct; 8(10):CR661-6. PubMed ID: 12388917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.